Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood - Fetal and Neonatal Edition 1999;80:F142-F145; doi:10.1136/fn.80.2.F142
Copyright © 1999 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.
Arch Dis Child Fetal Neonatal Ed 1999;80:F142-F145 ( March )

Unlicensed and off label drug use in neonates

Sharon Conroy, John McIntyre, Imti Choonara

Academic Division of Child Health, University of Nottingham, Derbyshire Children's Hospital, Derby DE22 3NE

Correspondence to: Mrs Sharon Conroy.


Accepted 19 October 1998

AIM---To determine the extent of use of drugs that are either not licensed (unlicensed), or are outside the terms of their product licence (off label) in a neonatal intensive care unit.
METHODS---A prospective study was conducted over 13 weeks.
RESULTS---455 prescription episodes were administered to 70 babies. 63 (90%) patients were given a drug that was either unlicensed or used in an off label way. 54.7% prescription episodes were off label, many for more than one reason, and 9.9% (45) were unlicensed; 35.4% (161) prescription episodes were licensed.
CONCLUSION---The use of unlicensed and off label drugs in neonatal intensive care seems to be far greater than other paediatric settings. This highlights the difficulties faced by those trying to ensure safe and effective prescribing for neonates. Urgent action is required to resolve this situation.

Keywords: unlicensed/off label drug use; intensive care


© 1999 by Archives of Disease in Childhood

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Sammons, H (2009). Ethical issues of clinical trials in children: a European perspective. Arch. Dis. Child. 94: 474-477 [Abstract] [Full Text]  
  • Cheng, K, Masters, S, Stephenson, T, Cooke, R, Ferner, R, Ashworth, M, Nunn, A J (2008). Identification of suspected fatal adverse drug reactions by paediatricians: a UK surveillance study. Arch. Dis. Child. 93: 609-611 [Abstract] [Full Text]  
  • Balakrishnan, K., Grieve, J., Tordoff, J., Norris, P., Reith, D. (2006). Pediatric licensing status and the availability of suitable formulations for new medical entities approved in the United States between 1998 and 2002.. J Clin Pharmacol 46: 1038-1043 [Abstract] [Full Text]  
  • Choonara, I (2006). Improving children's medicines. Arch. Dis. Child. 91: 550-551 [Full Text]  
  • Stephenson, T, Budge, H (2006). The future of neonatal therapeutic trials.. Arch. Dis. Child. Fetal Neonatal Ed. 91: F305-F307 [Abstract] [Full Text]  
  • McLay, J S, Tanaka, M, Ekins-Daukes, S, Helms, P J (2006). A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatricians. Arch. Dis. Child. 91: 584-587 [Abstract] [Full Text]  
  • Kunac, D L, Reith, D M, Kennedy, J, Austin, N C, Williams, S M (2006). Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients.. Qual Saf Health Care 15: 196-201 [Abstract] [Full Text]  
  • Eiland, L. S., Knight, P. (2006). Evaluating the off-label use of medications in children.. Am J Health Syst Pharm 63: 1062-1065 [Full Text]  
  • Zuppa, A. F., Adamson, P. C., Mondick, J. T., Davis, L. A., Maka, D. A., Narayan, M., Nicholson, C., Patel, D., Collison, K. R., Barrett, J. S. (2005). Drug Utilization in the Pediatric Intensive Care Unit: Monitoring Prescribing Trends and Establishing Prioritization of Pharmacotherapeutic Evaluation of Critically Ill Children. J Clin Pharmacol 45: 1305-1312 [Abstract] [Full Text]  
  • Chappell, K, Newman, C (2004). Potential tenfold drug overdoses on a neonatal unit. Arch. Dis. Child. Fetal Neonatal Ed. 89: F483-F484 [Abstract] [Full Text]  
  • Sammons, H M, McIntyre, J, Choonara, I (2004). Research in general paediatrics. Arch. Dis. Child. 89: 408-410 [Full Text]  
  • 't Jong, G.W., Eland, I.A., Sturkenboom, M.C.J.M., van den Anker, J.N., Stricker, B.H.C. (2004). Unlicensed and off-label prescription of respiratory drugs to children. Eur Respir J 23: 310-313 [Abstract] [Full Text]  
  • Roberts, R., Rodriguez, W., Murphy, D., Crescenzi, T. (2003). Pediatric Drug Labeling: Improving the Safety and Efficacy of Pediatric Therapies. JAMA 290: 905-911 [Abstract] [Full Text]  
  • Nunn, A J (2003). Making medicines that children can take. Arch. Dis. Child. 88: 369-371 [Full Text]  
  • Schirm, E., Tobi, H., de Jong-van den Berg, L. T.W. (2003). Risk Factors for Unlicensed and Off-Label Drug Use in Children Outside the Hospital. Pediatrics 111: 291-295 [Abstract] [Full Text]  
  • Boos, J. (2003). Off label use--label off use?. Ann Oncol 14: 1-5 [Full Text]  
  • Conroy, S., Newman, C., Gudka, S. (2003). Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children. Ann Oncol 14: 42-47 [Abstract] [Full Text]  
  • O'Donnell, C. P. F., Stone, R. J., Morley, C. J. (2002). Unlicensed and Off-Label Drug Use in an Australian Neonatal Intensive Care Unit. Pediatrics 110: e52-52 [Abstract] [Full Text]  
  • Guiton, S, Reith, D. M, Isitt, V. L (2002). Off label prescribing in children. BMJ 325: 338-338 [Full Text]  
  • 't Jong, G. W., Vulto, A. G., de Hoog, M., Schimmel, K. J. M., Tibboel, D., van den Anker, J. N. (2001). A Survey of the Use of Off-Label and Unlicensed Drugs in a Dutch Children's Hospital. Pediatrics 108: 1089-1093 [Abstract] [Full Text]  
  • Stephenson, T (2001). Current topic: Medicines for children{---}the last century and the next. Arch. Dis. Child. 85: 177-179 [Full Text]  
  • MARCOVITCH, H. (2000). . Arch. Dis. Child. 83: 0-0 [Full Text]  
  • McIntyre, J, Conroy, S, Avery, A, Corns, H, Choonara, I (2000). Unlicensed and off label prescribing of drugs in general practice. Arch. Dis. Child. 83: 498-501 [Abstract] [Full Text]  
  • Chalumeau, M, Tréluyer, J M, Salanave, B, Assathiany, R, Chéron, G, Crocheton, N, Rougeron, C, Mares, M, Bréart, G, Pons, G (2000). Off label and unlicensed drug use among French office based paediatricians. Arch. Dis. Child. 83: 502-505 [Abstract] [Full Text]  
  • Choonara, I. (2000). Clinical trials of medicines in children. BMJ 321: 1093-1094 [Full Text]  
  • Conroy, S., Choonara, I., Impicciatore, P., Mohn, A., Arnell, H., Rane, A., Knoeppel, C., Seyberth, H., Pandolfini, C., Raffaelli, M. P., Rocchi, F., Bonati, M., Jong, G.`t, de Hoog, M., van den Anker, J. (2000). Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 320: 79-82 [Abstract] [Full Text]  
  • HEY, E (2000). Unlicensed and off label drug use in neonates • Editors' comments. Arch. Dis. Child. Fetal Neonatal Ed. 82: 77F-77 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs